Determinants of hypertension and left ventricular function in end stage renal failure: A pilot study using cardiovascular magnetic resonance imaging

Clinical Physiology and Functional Imaging

Volumn 24, Issue 6, 2004, Pages 387-393

  Stewart, Graham A ^a   Mark, Patrick B ^a   Johnston, Nicola ^a   Foster, John E ^a   Cowan, Michael ^a   Rodger, R Stuart C ^a   Dargie, Henry J ^a   Jardine, Alan G ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Anaemia; Cardiac magnetic resonance imaging; Cardiac output; Haemodialysis; Hypertension

Indexed keywords

HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MASS; HEART OUTPUT; HEART STROKE VOLUME; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PRIORITY JOURNAL; SYSTEMIC VASCULAR RESISTANCE;

EID: 8844244014     PISSN: 14750961     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2004.00583.x     Document Type: Article

References (18)

1. Abraham PA, Opsahl JA, Keshaviah PR, Collins AJ, Whalen JJ, Asinger RW, McLain LA, Hanson G, Davis MG, Halstenson CE. Body fluid spaces and blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin. Am J Kidney Dis (1990); 16: 438-446.
2. Bellenger NG, Burgess M, Ray SG, Lahiri A, Coats AJ, Cleland JG, Pennell DJ. On behalf of the CHRISTMAS Steering committee and Investigators. Comparison of left ventricular ejection fraction and volumes in heart failure by two-dimensional echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance: are they interchangeable? Eur Heart J(2000a); 21: 1387-1396.
3. Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ. Reduction in sample size for studies of remodelling in heart failure by the use of cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance (2000b); 2: 271-278.
4. Berweck S, Hennig L, Sternberg C, Dingerkus H, Ludat K, Hampl H. Cardiac mortality prevention in uraemic patients. Therapeutic strategies with particular attention to complete correction of anaemia. Clin Nephrol (2000); 53: S80-S85.
5. Bottini PB, Carr AA, Prisant LM, Flicklinger FW, Allison JD, Gottdiener JS. Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertension (1995); 8: 221-228.
6. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B, Pasticci F, Kaufman JM, Buoncristiani U. Short daily haemodialysis: blood pressure control and left ventricular mass reduction in hypertensive haemodialysis patients. Am J Kidney Dis (2001); 38: 371-376.
7. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int (1998a); 54: 1720-1725.
8. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of Cardiovascular disease in chronic renal disease. J Am Soc Nephrology (1998b); 9: S31-S23.
9. Goldberg N, Lundin AP, Delano B, Friedman EA, Stein RA. Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietin. Am Heart J (1992); 124: 424-427.
10. Harnett JD, Barre PE, Taylor R, Taylor R, Parfrey PS. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrology (1994); 4: 1486-1490.
11. Hunold P, Vogt FM, Heeman UW, Zimmerman U, Barkhausen J. Myocardial mass and volume measurement of hypertrophic left ventricles by MRI-study in dialysis patients examined before and after dialysis. J Cardiovasc Magn Reson (2003); 5: 553-561.
12. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PW, Wright JT. Controlling the epidemic of cardiovascular disease in chronic renal failure. Am J Kidney Dis (1998); 32: 853-906.
13. Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP. Normal human right and left ventricular mass, systolic function and gender differences by cine magnetic resonance imaging. Journal of Cardiovascular Magnetic Resonance (1999); 1: 7-21.
14. Massimetti C, Pontillo D, Feriozzi S, Costantini S, Capezzuto A, Ancarani E. Impact of recombinant human erythropoietin treatment on ventricular hypertrophy and cardiac function in dialysis patients. Blood Purif (1998); 16: 317-325.
15. McGregor E, Jardine AG, Murray LS, Dargie HJ, Rodger RSC, Junor BJR, McMillan MA, Briggs JD. Pre-operative echocardiographic abnormalities and adverse outcome following renal transplantation. Nephrol Dial Transplant (1998); 13: 1499-1505.
16. Moon JCC, Lorenz CH, Francis JM, Smith GC, Pennell DJ. Breath-hold FLASH and FISP cardiovascular MR imaging: left ventricular volume differences and reproducibility. Radiology (2002); 223 789-797.
17. Stewart GA, Foster J, Cowan M, Rooney E, McDonagh T, Dargie HJ, Rodger RS, Jardine AG. Echocardiography overestimates left ventricular mass in haemodialysis patients relative to magnetic resonance imaging. Kidney Int (1999); 56: 2248-2253.
18. Wang MC, Tseng CC, Tsai WC, Huang JJ. Blood pressure and left ventricular hypertrophy in patients on different peritoneal dialysis regimens. Perit Dial Int (2001); 1: 36-42.